Global Health Ventures To Initiate Human Clinical Trials In Europe For X-Excite, Its Male Sexual Enhancement Drug
Global Health Ventures Inc. (OTCBB:GHLV), or the "Company", is pleased to announce that it has engaged Clinical Investigations Ltd. of United Kingdom to design and carry out the human clinical trials for X-Excite in Europe under the European Regulatory Guidelines (EMEA)...